Joseph Romanelli insider trades
Open-market stock purchases and sales by Joseph Romanelli, President, Human Health Int?l at Merck & Co, Inc, from SEC Form 4 filings since Dec 2, 2022.
Track record: 100% of 8 scored buys are up 5% or more since purchase, averaging +24%.